Subtopic Deep Dive
Homeostasis Model Assessment of Insulin Resistance
Research Guide
What is Homeostasis Model Assessment of Insulin Resistance?
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) quantifies insulin resistance using the formula (fasting glucose × fasting insulin) / 22.5 from single fasting blood samples.
HOMA-IR serves as a surrogate for euglycemic-hyperinsulinemic clamp measurements in large epidemiological studies. HOMA-β estimates β-cell function similarly. Validated in cohorts with impaired glucose tolerance and type 2 diabetes (Abdul-Ghani et al., 2006; 492 citations; Díz et al., 2013; 527 citations).
Why It Matters
HOMA-IR enables insulin resistance screening in population studies without invasive clamps, identifying metabolic syndrome risks adjusted for gender and age (Díz et al., 2013). It tracks β-cell dysfunction progression in prediabetes, informing early interventions (Abdul-Ghani et al., 2006). DeFronzo's framework integrates HOMA-IR into type 2 diabetes pathophysiology, guiding therapies targeting muscle/liver resistance and β-cell failure (DeFronzo, 2009; 2918 citations).
Key Research Challenges
HOMA-IR Cut-off Variability
Gender and age alter optimal HOMA-IR thresholds for metabolic syndrome detection. EPIRCE study proposes risk-based cut-offs over percentiles (Díz et al., 2013; 527 citations). Standardization across populations remains inconsistent.
Validation Against Gold Standards
HOMA-IR correlates with clamps but overestimates resistance in severe cases. Abdul-Ghani et al. show differential insulin secretion/action in IFG/IGT using OGTT alongside HOMA (2006; 492 citations). Longitudinal accuracy needs refinement.
β-Cell Function Overestimation
HOMA-β assumes steady-state fasting conditions, inaccurate postprandially. DeFronzo highlights early β-cell failure underestimated by fasting models (2009; 2918 citations). Dynamic tests like IVGTT provide better resolution.
Essential Papers
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
Ralph A. DeFronzo · 2009 · Diabetes · 2.9K citations
Insulin resistance in muscle and liver and β-cell failure represent the core pathophysiologic defects in type 2 diabetes. It now is recognized that the β-cell failure occurs much earlier and is mor...
The use of animal models in diabetes research
Aileen King · 2012 · British Journal of Pharmacology · 1.3K citations
Diabetes is a disease characterized by a relative or absolute lack of insulin, leading to hyperglycaemia. There are two main types of diabetes: type 1 diabetes and type 2 diabetes. Type 1 diabetes ...
Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study
Pilar Díz, Alfonso Otero-González, María Xosé Rodríguez‐Álvarez et al. · 2013 · BMC Endocrine Disorders · 527 citations
The consideration of the cardio metabolic risk to establish the cut-off points of HOMA-IR, to define insulin resistance instead of using a percentile of the population distribution, would increase ...
Insulin Secretion and Action in Subjects With Impaired Fasting Glucose and Impaired Glucose Tolerance
Muhammad Abdul‐Ghani, Christopher P. Jenkinson, Dawn K. Richardson et al. · 2006 · Diabetes · 492 citations
This study was conducted to observe changes in insulin secretion and insulin action in subjects with impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT). A total of 319 subjects ...
Effect of Initial Combination Therapy With Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, and Metformin on Glycemic Control in Patients With Type 2 Diabetes
Barry J. Goldstein, Mark N. Feinglos, Jared Lunceford et al. · 2007 · Diabetes Care · 487 citations
OBJECTIVE—To assess the efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes and inadequate glycemic control on diet and exercise. RESE...
Impact of postprandial glycaemia on health and prevention of disease
Ellen E. Blaak, Jean Michel Antoine, David Benton et al. · 2012 · Obesity Reviews · 456 citations
Summary Postprandial glucose, together with related hyperinsulinemia and lipidaemia, has been implicated in the development of chronic metabolic diseases like obesity, type 2 diabetes mellitus (T2D...
Long-Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer's Disease Dementia
Amy Claxton, Laura D. Baker, Angela J. Hanson et al. · 2015 · Journal of Alzheimer s Disease · 454 citations
Previous trials have shown promising effects of intranasally administered insulin for adults with Alzheimer's disease dementia (AD) or amnestic mild cognitive impairment (MCI). These trials used re...
Reading Guide
Foundational Papers
Start with DeFronzo (2009; 2918 citations) for pathophysiological context of insulin resistance; Abdul-Ghani et al. (2006; 492 citations) for empirical validation in prediabetes; Díz et al. (2013; 527 citations) for practical cut-offs.
Recent Advances
Dennis et al. (2019; 452 citations) on data-driven T2D subgroups using HOMA-like metrics; Claxton et al. (2015; 454 citations) extends to insulin's cognitive effects measurable via HOMA.
Core Methods
Fasting glucose/insulin product divided by 22.5 (HOMA-IR); HOMA-β = (20 × fasting insulin) / (glucose - 3.5). OGTT/euglycemic clamp for validation.
How PapersFlow Helps You Research Homeostasis Model Assessment of Insulin Resistance
Discover & Search
Research Agent uses searchPapers and citationGraph on DeFronzo (2009; 2918 citations) to map HOMA-IR's role in the 'Ominous Octet,' revealing 50+ citing papers on insulin resistance surrogates. exaSearch finds EPIRCE validations (Díz et al., 2013), while findSimilarPapers uncovers cohort-specific cut-offs.
Analyze & Verify
Analysis Agent applies readPaperContent to extract HOMA-IR formulas from Abdul-Ghani et al. (2006), then runPythonAnalysis computes correlations with OGTT data using pandas/NumPy. verifyResponse (CoVe) and GRADE grading confirm cut-off validity from Díz et al. (2013) against metabolic risks.
Synthesize & Write
Synthesis Agent detects gaps in age/gender-adjusted HOMA-IR models, flagging contradictions between DeFronzo (2009) and prediabetes studies. Writing Agent uses latexEditText, latexSyncCitations for HOMA-IR review papers, latexCompile for publication-ready docs, and exportMermaid for insulin resistance pathway diagrams.
Use Cases
"Recalculate HOMA-IR cut-offs from EPIRCE data for my cohort"
Research Agent → searchPapers(EPIRCE) → Analysis Agent → readPaperContent → runPythonAnalysis(pandas threshold modeling) → CSV export of gender/age stratified values.
"Draft LaTeX review on HOMA-IR validation studies"
Research Agent → citationGraph(DeFronzo 2009) → Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations(Abdul-Ghani 2006, Díz 2013) → latexCompile → PDF output.
"Find code for HOMA-IR calculators from papers"
Research Agent → paperExtractUrls(HOMA papers) → Code Discovery → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis on extracted scripts for fasting glucose/insulin simulations.
Automated Workflows
Deep Research workflow conducts systematic HOMA-IR review: searchPapers(250+ hits) → citationGraph → DeepScan(7-step analysis with GRADE on DeFronzo/EPIRCE) → structured report. Theorizer generates hypotheses on HOMA-β improvements from Abdul-Ghani (2006) secretion data. DeepScan verifies cut-off generalizability across cohorts with CoVe checkpoints.
Frequently Asked Questions
What is the HOMA-IR formula?
HOMA-IR = (fasting glucose (mmol/L) × fasting insulin (μU/mL)) / 22.5. Derived from hepatic/muscle resistance models under fasting steady-state.
What are common HOMA-IR methods?
Computed from single fasting samples; validated via OGTT correlations (Abdul-Ghani et al., 2006). Cut-offs vary: EPIRCE suggests gender/age-adjusted thresholds (Díz et al., 2013).
What are key HOMA-IR papers?
DeFronzo (2009; 2918 citations) frames pathophysiology; Díz et al. (2013; 527 citations) provide population cut-offs; Abdul-Ghani et al. (2006; 492 citations) validate in IFG/IGT.
What are open problems in HOMA-IR research?
Ethnic/population-specific cut-offs; integration with dynamic tests; overestimation in advanced β-cell failure (DeFronzo, 2009).
Research Diabetes Management and Research with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching Homeostasis Model Assessment of Insulin Resistance with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
Part of the Diabetes Management and Research Research Guide